{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T22:30:53Z","timestamp":1794349853472,"version":"4.9.0"},"reference-count":115,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ijbiomac.2024.134144","type":"journal-article","created":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T19:50:10Z","timestamp":1721764210000},"page":"134144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"P1","title":["Lactoferrin, chitosan double-coated oleosomes loaded with clobetasol propionate for remyelination in multiple sclerosis: Physicochemical characterization and in-vivo assessment in a cuprizone-induced demyelination model."],"prefix":"10.1016","volume":"277","author":[{"given":"Lamiaa R.","family":"Abdelalim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosra S.R.","family":"Elnaggar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ossama Y.","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2024.134144_bb0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ene.12798","article-title":"A basic overview of multiple sclerosis immunopathology","volume":"22","author":"Grigoriadis","year":"2015","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0010","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s12026-015-8719-0","article-title":"Advancing drug delivery systems for the treatment of multiple sclerosis","volume":"63","author":"Tabansky","year":"2015","journal-title":"Immunol. Res."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0015","doi-asserted-by":"crossref","unstructured":"C. Walton, R. King, L. Rechtman, W. Kaye, E. Leray, R.A. Marrie, N. Robertson, N. La Rocca, B. Uitdehaag, I. van der Mei, M. Wallin, A. Helme, R.K. Ceri AngoodClare Walton, L. Rechtman, W. Kaye, E. Leray, R.A. Marrie, N. Robertson, N. La Rocca, B. Uitdehaag, I. van der Mei, M. Wallin, A. Helme, C.A. Napier, N. Rijke, Rising prevalence of multiple sclerosis worldwide: insights from the atlas of MS, third edition, Mult. Scler. J. 26 (2020) 1816\u20131821. https:\/\/doi.org\/10.1177\/https.","DOI":"10.1177\/1352458520970841"},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0020","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1002\/eji.201646485","article-title":"Current multiple sclerosis treatments have improved our understanding of MS autoimmune pathogenesis","volume":"46","author":"Martin","year":"2016","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0025","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.biopha.2016.12.010","article-title":"Multiple sclerosis: therapeutic applications of advancing drug delivery systems","volume":"86","author":"Dolati","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0030","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jocit.2017.12.001","article-title":"A review on nanotechnology based innovations in diagnosis and treatment of multiple sclerosis","volume":"4","author":"Ojha","year":"2018","journal-title":"J. Cell. Immunother."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0035","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1007\/s00415-019-09395-w","article-title":"Comparative efficacy and acceptability of disease-modifying therapies in patients with relapsing-remitting multiple sclerosis: a systematic review and network metaanalysis","volume":"267","author":"Li","year":"2020","journal-title":"J. Neurol."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0040","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nature14335","article-title":"Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo","volume":"522","author":"Najm","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0045","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00415-019-09421-x","article-title":"Promoting remyelination in multiple sclerosis","volume":"268","author":"Cunniffe","year":"2021","journal-title":"J. Neurol."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0050","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40478-016-0309-4","article-title":"Clobetasol promotes remyelination in a mouse model of neuromyelitis optica","volume":"4","author":"Yao","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0055","first-page":"S50","article-title":"Corticosteroids: options in the era of steroi-sparing therapy, J. Am. Acad","volume":"53","author":"Rosso","year":"2005","journal-title":"Dermatology"},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0060","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/jps.10536","article-title":"Evaluation of in vivo bioequivalence methodology for topical clobetasol 17-propionate based on pharmacodynamic modeling using Chinese skin","volume":"93","author":"Tsai","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0065","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0149-2918(98)80032-5","article-title":"The role of clobetasol propionate emollient 0.05% in the treatment of patients with dry, scaly, corticosteroid-responsive dermatoses","volume":"20","author":"Gordon","year":"1998","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0070","first-page":"435","article-title":"Pharmaceutical availability of clobetasol 17-propionate from cream and ointment., Acta pol","volume":"58","author":"Dyderski","year":"2001","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0075","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1046\/j.1365-2230.2001.00855.x","article-title":"Bone mineral density of patients with chronic plaque psoriasis","volume":"26","author":"Millard","year":"2001","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0080","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/archderm.1978.01640180085023","article-title":"Glaucoma induced by application of corticosteroids to the periorbital region","volume":"114","author":"Nielsen","year":"1978","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0144550","article-title":"Clobetasol and halcinonide act as smoothened agonists to promote myelin gene expression and RxR\u03b3 receptor activation","volume":"10","author":"Porcu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0090","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000509521","article-title":"Clobetasol attenuates white matter injury by promoting oligodendrocyte precursor cell differentiation","volume":"55","author":"Su","year":"2020","journal-title":"Pediatr. Neurosurg."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0095","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-021-03907-1","article-title":"Clobetasol promotes neuromuscular plasticity in mice after motoneuronal loss via sonic hedgehog signaling, immunomodulation and metabolic rebalancing","volume":"12","author":"Vicario","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0100","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1021\/acsbiomaterials.8b01297","article-title":"Sericin nerve guidance conduit delivering therapeutically repurposed clobetasol for functional and structural regeneration of transected peripheral nerves","volume":"5","author":"Zhang","year":"2019","journal-title":"ACS Biomater Sci. Eng."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0105","first-page":"1258","article-title":"Clobetasol propionate enhances neural stem cell and oligodendrocyte differentiation","author":"Shi","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0110","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S0022-2275(20)32548-7","article-title":"Liposomes enriched in oleic acid are less susceptible to oxidation and have less proinflammatory activity when exposed to oxidizing conditions","volume":"39","author":"Lee","year":"1998","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0115","article-title":"Liposomes in cosmetics","volume":"3","author":"Ashtiani","year":"2016","journal-title":"J. Ski. Stem Cell"},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0120","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ijpharm.2005.10.008","article-title":"Interactions of oleic acid and model stratum corneum membranes as seen by 2 H NMR","volume":"307","author":"Rowat","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-020-01862-2","article-title":"Oleosomes encapsulating sildenafil citrate as potential topical Nanotherapy for palmar plantar Erythrodysesthesia with high ex vivo permeation and deposition","volume":"21","author":"Abdelalim","year":"2020","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0130","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1080\/21691401.2017.1307209","article-title":"Enhancement of antimicrobial activity by liposomal oleic acid-loaded antibiotics for the treatment of multidrug-resistant Pseudomonas aeruginosa","volume":"46","author":"Selvadoss","year":"2018","journal-title":"Artif. Cells, Nanomedicine, Biotechnol."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0135","first-page":"404","article-title":"T, Opanasopit","volume":"13","author":"Subongkot","year":"2021","journal-title":"Development of ultradeformable liposomes with fatty acids for enhanced dermal rosmarinic acid delivery, Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0140","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s11947-020-02419-8","article-title":"Effect of oleic acid, cholesterol, and octadecylamine on membrane stability of freeze-dried liposomes encapsulating natural antimicrobials","volume":"13","author":"Pinilla","year":"2020","journal-title":"Food Bioprocess Technol."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0145","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3390\/molecules26010205","article-title":"Lactoferrin: a glycoprotein involved in immunomodulation, anticancer, and antimicrobial processes","volume":"26","author":"Rasc\u00f3n-Cruz","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0150","first-page":"1","article-title":"Lactoferrin for mental health: neuro-redox regulation and neuroprotective effects across the blood-brain barrier with special reference to neuro-COVID-19","volume":"0","author":"Naidu","year":"2021","journal-title":"J. Diet. Suppl."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0155","first-page":"1342","article-title":"Neuroprotective effects of Lactoferrin in Alzheimer\u2019s and Parkinson\u2019s diseases: a narrative review","volume":"14","author":"Yong","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0160","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10534-022-00453-x","article-title":"Lactoferrin: from the structure to the functional orchestration of iron homeostasis","volume":"36","author":"Ianiro","year":"2023","journal-title":"Biometals"},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0165","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jneuroim.2006.10.008","article-title":"Lactoferrin ameliorates symptoms of experimental encephalomyelitis in Lewis rats","volume":"182","author":"Zimecki","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0170","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.2174\/138161209788453202","article-title":"Lactoferrin as a natural immune modulator Jeffrey","volume":"15","author":"Actor","year":"2009","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0175","doi-asserted-by":"crossref","first-page":"7011","DOI":"10.1074\/jbc.274.11.7011","article-title":"Receptor-mediated transcytosis of Lactoferrin through the blood-brain barrier","volume":"274","author":"Fillebeen","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0180","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/aps.2009.199","article-title":"Effect of lactoferrin- and transferrin-conjugated polymersomes in brain targeting: in vitro and in vivo evaluations","volume":"31","author":"Le Gao","year":"2010","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0185","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.msec.2018.02.004","article-title":"Design of lactoferrin modified lipid nano-carriers for efficient brain-targeted delivery of nimodipine","volume":"92","author":"Zhao","year":"2018","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0190","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.biomaterials.2007.09.024","article-title":"The use of lactoferrin as a ligand for targeting the polyamidoamine-based gene delivery system to the brain","volume":"29","author":"Huang","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0195","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3109\/1061186X.2015.1068320","article-title":"Lactoferrin bioconjugated solid lipid nanoparticles: a new drug delivery system for potential brain targeting","volume":"24","author":"Singh","year":"2016","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0200","article-title":"Chitosan nanoparticles to enhance nasal absorption and brain targeting of sitagliptin to treat Alzheimer\u2019s disease","volume":"61","author":"Wilson","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15030851","article-title":"Self-assembled lecithin-chitosan nanoparticles improved Rotigotine nose-to-brain delivery and brain targeting efficiency","volume":"15","author":"Saha","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0210","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1080\/02652048.2017.1375039","article-title":"Evaluation of brain-targeted chitosan nanoparticles through blood\u2013brain barrier cerebral microvessel endothelial cells","volume":"34","author":"Sahin","year":"2017","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0215","first-page":"1","article-title":"A reevaluation of chitosan-decorated nanoparticles to cross the blood-brain barrier","volume":"10","author":"Cort\u00e9s","year":"2020","journal-title":"Membranes (Basel)"},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics12111013","article-title":"Overcoming the blood-brain barrier: functionalised chitosan nanocarriers","volume":"12","author":"Caprifico","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0225","doi-asserted-by":"crossref","DOI":"10.3390\/md15040089","article-title":"An overview of the protective effects of chitosan and acetylated chitosan oligosaccharides against neuronal disorders","volume":"15","author":"Hao","year":"2017","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.reactfunctpolym.2019.104459","article-title":"Chitosan as a coating material for nanoparticles intended for biomedical applications","volume":"147","author":"Frank","year":"2020","journal-title":"React. Funct. Polym."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0235","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ijpharm.2019.02.012","article-title":"Chitosan and chitosan coating nanoparticles for the treatment of brain disease","volume":"560","author":"Yu","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0240","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.3390\/md8072117","article-title":"Neuroprotective properties of chitosan and its derivatives","volume":"8","author":"Pangestuti","year":"2010","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0245","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.neulet.2008.08.040","article-title":"Chitooligosaccharides protect cultured hippocampal neurons against glutamate-induced neurotoxicity","volume":"444","author":"Zhou","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0250","doi-asserted-by":"crossref","unstructured":"C. Quispe Rodrigo, A. Trevino Jorge, K. Faizan, N. Vera, Non-invasive strategies for nose-to-brain drug delivery, J. Clin. Trials 10 (2019) 96\u2013108. 10.46354\/i3m.2019.iwish.017.","DOI":"10.46354\/i3m.2019.iwish.017"},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0255","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/10717544.2013.838713","article-title":"Insights into direct nose to brain delivery: current status and future perspective","volume":"21","author":"Mittal","year":"2014","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0260","unstructured":"L. Illum, Potential for nose-to-brain delivery of drugs, in: Nanoparticles Lung Environ. Expo. Drug Deliv., 2014: pp. 1\u2013368."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0265","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1211\/0022357022539","article-title":"Is nose-to-brain transport of drugs in man a reality?","volume":"56","author":"Illum","year":"2004","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0270","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4155\/tde.11.149","article-title":"Nasal-to-CNS drug delivery: where are we now and where are we heading? An industrial perspective","volume":"3","author":"Landis","year":"2012","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0275","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/jemt.1070230105","article-title":"Morphology of olfactory epithelium in humans and other vertebrates","volume":"23","author":"Morrison","year":"1992","journal-title":"Microsc. Res. Tech."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0280","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/jps.21924","article-title":"Intranasal delivery to the central nervous system: mechanisms and experimental considerations","volume":"99","author":"Dhuria","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0285","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jconrel.2014.06.053","article-title":"Quantitative analysis of drug delivery to the brain via nasal route","volume":"189","author":"Kozlovskaya","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0290","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1021\/mp100029t","article-title":"Trigeminal pathways deliver a low molecular weight drug from the nose to the brain and orofacial structures","volume":"7","author":"Johnson","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0295","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/cne.10143","article-title":"Trigeminal collaterals in the nasal epithelium and olfactory bulb: a potential route for direct modulation of olfactory information by trigeminal stimuli","volume":"444","author":"Schaefer","year":"2002","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0300","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1006\/abio.1999.4019","article-title":"Spectrophotometric quantitation of antioxidant capacity through the formation of a phosphomolybdenum complex: specific application to the determination of vitamin E1","volume":"269","author":"Prieto","year":"1999","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0305","doi-asserted-by":"crossref","DOI":"10.1177\/1759091417725174","article-title":"An alternative cuprizone-induced demyelination and Remyelination mouse model","volume":"9","author":"Zhen","year":"2017","journal-title":"ASN Neuro"},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0310","first-page":"1","article-title":"Intranasal administration of CNS therapeutics to awake mice","author":"Hanson","year":"2013","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep42323","article-title":"Modified forelimb grip strength test detects aging-associated physiological decline in skeletal muscle function in male mice","volume":"7","author":"Takeshita","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0320","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrn2652","article-title":"Tests to assess motor phenotype in mice: a user\u2019s guide","volume":"10","author":"Brooks","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0325","first-page":"31","article-title":"Genetic differences in response to novelty and spatial memory using a two-trial recognition task in mice, Neurobiol","volume":"73","author":"Dellu","year":"2000","journal-title":"Learn. Mem."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0330","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3390\/ijms21020646","article-title":"Differential expression of miRNAs and behavioral change in the cuprizone-induced demyelination mouse model","volume":"21","author":"Han","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0335","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.neubiorev.2019.08.008","article-title":"Behavioural phenotypes in the cuprizone model of central nervous system demyelination","volume":"107","author":"Sen","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0340","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1042\/AN20090032","article-title":"Cuprizone demyelination of the corpus callosum in mice correlates with altered social interaction and impaired bilateral sensorimotor coordination","volume":"1","author":"Hibbits","year":"2009","journal-title":"ASN Neuro"},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0345","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF02540959","article-title":"Coloring conditions of thiobarbituric acid test for detecting lipid hydroperoxides","volume":"15","author":"Asakawa","year":"1980","journal-title":"Lipids"},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0350","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00216-006-0375-8","article-title":"Rapid determination of reduced and oxidized glutathione levels using a new thiol-masking reagent and the enzymatic recycling method: application to the rat liver and bile samples","volume":"385","author":"Shaik","year":"2006","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0355","first-page":"158","article-title":"Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase","volume":"70","author":"Paglia","year":"1967","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0360","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ijbiomac.2022.01.100","article-title":"Glutathione targeted tragacanthic acid-chitosan as a non-viral vector for brain delivery of miRNA-219a-5P: an in vitro\/in vivo study","volume":"200","author":"Shamaeizadeh","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0365","unstructured":"B. J.D., A. Stevens, Theory and Practice of Histological Techniques, 1996."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0370","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/jcbfm.2014.6","article-title":"Repeated mild traumatic brain injury results in long-term white-matter disruption","volume":"34","author":"Donovan","year":"2014","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0375","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3390\/cells8060552","article-title":"Agenesis and hypomyelination of Corpus callosum in mice lacking Nsun5, an RNA methyltransferase","volume":"8","author":"Yuan","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0380","first-page":"139","article-title":"The cysteine-rich whey protein supplement, Immunocal\u00ae, preserves brain glutathione and improves cognitive, motor, and histopathological indices of traumatic brain injury in a mouse model of controlled cortical impact","volume":"176","author":"Ignowski","year":"2017","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e09394","article-title":"Liposomes: structure, composition, types, and clinical applications","volume":"8","author":"Nsairat","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0390","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.3390\/app9173445","article-title":"Surface, volumetric, and wetting properties of oleic, linoleic, and linolenic acids with regards to application of canola oil in diesel engines","volume":"9","author":"Zdziennicka","year":"2019","journal-title":"Appl. Sci."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0395","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000441040","article-title":"A comparison of the penetration and permeation of caffeine into and through human epidermis after application in various vesicle formulations","volume":"29","author":"Abd","year":"2016","journal-title":"Skin Pharmacol. Physiol."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0400","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.carbpol.2014.04.038","article-title":"Layer-by-layer assembly of chitosan stabilized multilayered liposomes for paclitaxel delivery","volume":"111","author":"Chen","year":"2014","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0405","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.foodhyd.2015.08.016","article-title":"Biopolymer-coated liposomes by electrostatic adsorption of chitosan (chitosomes) as novel delivery systems for carotenoids","volume":"52","author":"Tan","year":"2016","journal-title":"Food Hydrocoll."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0410","doi-asserted-by":"crossref","unstructured":"S. G, van H. J, van R. S, D. CD, Drukarch B, de V. HE., Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathology, Brain Res. Rev. 56 (2007) 322\u2013330.","DOI":"10.1016\/j.brainresrev.2007.07.005"},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0415","doi-asserted-by":"crossref","unstructured":"A. Had\u017eovi\u0107-D\u017euvo, O. Lepara, A. Valjevac, N. Avdagi\u0107, S. Hasi\u0107, E. Kiseljakovi\u0107, S. Ibragi\u0107, A. Alajbegovi\u0107, Serum total antioxidant capacity in patients with multiple sclerosis, Bosn. J. Basic Med. Sci. 11 (2011) 33\u201336. 10.17305\/bjbms.2011.2620.","DOI":"10.17305\/bjbms.2011.2620"},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0420","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s11094-020-02194-y","article-title":"Biological and phytochemicals properties of monothecalbuxifolia: an unexplored medicinal plant","volume":"54","author":"Khan","year":"2020","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0425","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.3390\/molecules24112074","article-title":"Gallic acid-chitosan conjugate inhibits the formation of calcium oxalate crystals","volume":"24","author":"Queiroz","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0430","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.carbpol.2017.04.076","article-title":"Enhanced solubility and antioxidant activity of chlorogenic acid-chitosan conjugates due to the conjugation of chitosan with chlorogenic acid","volume":"170","author":"Rui","year":"2017","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0435","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4103\/2277-9175.164010","article-title":"Cytoprotective and antioxidant effects of human lactoferrin against H2O2-induced oxidative stress in human umbilical vein endothelial cells","volume":"4","author":"Safaeian","year":"2015","journal-title":"Adv. Biomed. Res."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0440","first-page":"1","article-title":"Determination of lactoferrin content and the total antioxidant capacity, in animal, or powdered milks and food supplements available in drugstore, using biosensors. Study of the possible correlation between them","volume":"12","author":"Tomassetti","year":"2016","journal-title":"Curr. Pharm. Anal."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0445","doi-asserted-by":"crossref","DOI":"10.1088\/1742-6596\/733\/1\/012039","article-title":"A comparison of TEM and DLS methods to characterize size distribution of ceramic nanoparticles","volume":"733","author":"Souza","year":"2016","journal-title":"J. Phys. Conf. Ser."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0450","doi-asserted-by":"crossref","DOI":"10.3390\/colloids7010015","article-title":"Dynamic light scattering: a powerful tool for in situ nanoparticle sizing","volume":"7","author":"Jia","year":"2023","journal-title":"Colloids Interfaces"},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0455","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/0041-008X(66)90062-7","article-title":"Response of mice to the chelating agents sodium diethyldithiocarbamate, \u03b1-benzoinoxime, and biscyclohexanone oxaldihydrazone","volume":"8","author":"Carlton","year":"1966","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0460","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1600-0404.2008.01036.x","article-title":"The cuprizone model for demyelination","volume":"117","author":"Torkildsen","year":"2008","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0465","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.neubiorev.2014.10.004","article-title":"Cellular and molecular neuropathology of the cuprizone mouse model: clinical relevance for multiple sclerosis","volume":"47","author":"Praet","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0470","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0165-5728(98)00168-4","article-title":"Microglial\/macrophage accumulation during cuprizone-induced demyelination in C57BL\/6 mice","volume":"92","author":"Hiremath","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0475","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.toxlet.2007.01.010","article-title":"Behavioral deficits in the cuprizone-induced murine model of demyelination\/remyelination","volume":"169","author":"Franco-Pons","year":"2007","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-01963-3","article-title":"Cuprizone feed formulation influences the extent of demyelinating disease pathology","volume":"11","author":"Toomey","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0485","first-page":"51303","article-title":"Assessing functional performance in the mdx mouse model","volume":"85","author":"Aartsma-Rus","year":"2014","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0490","first-page":"1","article-title":"Cuprizone-induced demyelination in mouse brain is not due to depletion of copper","volume":"14","author":"Morgan","year":"2022","journal-title":"Am. Soc. Neurochem."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0495","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/jnc.15142","article-title":"Acute motor deficit and subsequent remyelination-associated recovery following internal capsule demyelination in mice","volume":"156","author":"Yamazaki","year":"2021","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0500","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1080\/08923973.2021.1986063","article-title":"Tofacitinib enhances remyelination and improves myelin integrity in cuprizone-induced mice","volume":"43","author":"G\u00fcnayd\u0131n","year":"2021","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0505","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3390\/cells9040843","article-title":"The cuprizone model\u00a0: dos and do nots","volume":"9","author":"Zhan","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0510","first-page":"2711","article-title":"Cuprizone-induced demyelination in Wistar rats; electrophysiological and histological assessment","volume":"17","author":"Basoglu","year":"2013","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0515","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s12264-015-1555-3","article-title":"Clemastine rescues behavioral changes and enhances remyelination in the cuprizone mouse model of demyelination","volume":"31","author":"Li","year":"2015","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0520","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-90597-6","article-title":"Demyelination and remyelination detected in an alternative cuprizone mouse model of multiple sclerosis with 7.0 T multiparameter magnetic resonance imaging","volume":"11","author":"Ding","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0525","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.neuron.2018.01.021","article-title":"Multiple sclerosis\u00a0: mechanisms and immunotherapy","volume":"97","author":"Baecher-allan","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0530","doi-asserted-by":"crossref","first-page":"9327","DOI":"10.1523\/JNEUROSCI.1749-20.2020","article-title":"Ferroptosis mediates cuprizone-induced loss of oligodendrocytes and demyelination","volume":"40","author":"Jhelum","year":"2020","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0535","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-022-00538-8","article-title":"Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination","volume":"17","author":"Zirngibl","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2022.118935","article-title":"Abnormal oxidative metabolism in the cuprizone mouse model of demyelination: an in vivo NIRS-MRI study","volume":"250","author":"Hashem","year":"2022","journal-title":"Neuroimage"},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0545","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.foodchem.2017.02.127","article-title":"Measurement of antioxidant activity with the thiobarbituric acid reactive substances assay","volume":"230","author":"Ghani","year":"2017","journal-title":"Food Chem."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0550","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2478\/s11536-006-0008-9","article-title":"Estimate of antioxidant capacity and lipid peroxidation in plasma of healthy subjects","volume":"1","author":"Gor\u0105ca","year":"2006","journal-title":"Open Med."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0555","first-page":"644","article-title":"Investigation of neuro-inflammatory parameters in a cuprizone induced mouse model of multiple sclerosis, Turkish","volume":"45","author":"Av\u015far","year":"2021","journal-title":"J. Biol."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0560","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/jci.insight.87455","article-title":"Therapeutic inhibition of soluble brain TNF promotes remyelination by increasing myelin phagocytosis by microglia","volume":"2","author":"Karamita","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0565","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.intimp.2017.08.007","article-title":"Progesterone therapy induces an M1 to M2 switch in microglia phenotype and suppresses NLRP3 inflammasome in a cuprizone-induced demyelination mouse model","volume":"51","author":"Aryanpour","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0570","doi-asserted-by":"crossref","first-page":"13952","DOI":"10.1002\/jcb.28670","article-title":"Mesenchymal stem cell mediated effects on microglial phenotype in cuprizone-induced demyelination model","volume":"120","author":"Barati","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ijbiomac.2024.134144_bb0575","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1007\/s10787-022-01045-4","article-title":"Nebivolol elicits a neuroprotective effect in the cuprizone model of multiple sclerosis in mice: emphasis on M1\/M2 polarization and inhibition of NLRP3 inflammasome activation","volume":"30","author":"Naeem","year":"2022","journal-title":"Inflammopharmacology"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024049493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024049493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T22:23:12Z","timestamp":1786486992000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813024049493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":115,"alternative-id":["S0141813024049493"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.134144","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lactoferrin, chitosan double-coated oleosomes loaded with clobetasol propionate for remyelination in multiple sclerosis: Physicochemical characterization and in-vivo assessment in a cuprizone-induced demyelination model.","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.134144","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"134144"}}